- Home
- MAPS vs CLNN Comparison
MAPS vs CLNN Comparison
Compare MAPS & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAPS | CLNN |
|---|---|---|
| Founded | 2008 | 2012 |
| Country | United States | United States |
| Employees | 449 | 79 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.5M | 85.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MAPS | CLNN |
|---|---|---|
| Price | $0.36 | $6.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $2.61 | ★ $33.75 |
| AVG Volume (30 Days) | ★ 6.7M | 576.7K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17.64 |
| Revenue Next Year | $6.17 | $19,516.77 |
| P/E Ratio | $9.75 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.32 | $2.28 |
| 52 Week High | $1.36 | $13.50 |
Technical Indicators
Market Signals| Indicator | MAPS | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 33.93 | 51.57 |
| Support Level | $0.33 | $5.50 |
| Resistance Level | $0.75 | $6.92 |
| Average True Range (ATR) | 0.05 | 0.77 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 12.23 | 40.20 |
Price Performance
Historical ComparisonAbout MAPS WM Technology Inc.
WM Technology Inc operates an online cannabis marketplace for consumers, together with a comprehensive set of e-commerce and compliance software solutions for cannabis businesses, which are sold to both storefront locations and delivery operators (retailers) and brands in the legalized cannabis markets in states and territories of the United States. Its comprehensive business-to-consumer and business-to-business suite of products affords cannabis retailers and brands of all sizes integrated tools to compliantly run their businesses and to reach, convert, and retain consumers.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.